Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Edgewise Therapeutics Inc
(NQ:
EWTX
)
18.98
+0.25 (+1.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edgewise Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...
Via
Benzinga
Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
December 19, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Where Edgewise Therapeutics Stands With Analysts
August 16, 2023
Via
Benzinga
Analyst Ratings for Edgewise Therapeutics
June 27, 2023
Via
Benzinga
Edgewise Therapeutics: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Edgewise Therapeutics Launches First of Its Kind Educational Website Dedicated to the Becker Muscular Dystrophy Community
December 18, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Receives Orphan Drug and Rare Pediatric Disease Designations for Its Muscular Dystrophy Program from FDA
November 30, 2023
From
Edgewise Therapeutics
Via
Business Wire
Speculator’s Watch List: 7 Stocks Ripe for a Short-Squeeze Windfall
November 28, 2023
Although betting against the bears is risky, the rewards for targeting short-squeeze stocks can also be stratospheric.
Via
InvestorPlace
Edgewise Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 09, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at Upcoming Investor Conferences
November 08, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise to Present Data on EDG-7500 at the American Heart Association’s Scientific Sessions 2023
November 01, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Announces Expansion of their EDG-5506 Clinical Program in Duchenne Muscular Dystrophy (Duchenne)
October 26, 2023
From
Edgewise Therapeutics
Via
Business Wire
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
October 06, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Edgewise Therapeutics to Present on EDG-5506 for Becker Muscular Dystrophy at the 28th International Annual Congress of the World Muscle Society
September 27, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Announces Initiation of GRAND CANYON, a Global Pivotal Study of EDG-5506 in Becker Muscular Dystrophy (Becker)
September 26, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Begins Dosing First-in-Human Phase 1 Trial of EDG-7500, its Lead Clinical Candidate for Hypertrophic Cardiomyopathy (HCM) and Other Serious Diseases of Cardiac Diastolic Dysfunction
September 14, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
From
Edgewise Therapeutics
Via
Business Wire
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
CIRCOR International, Enovix, Edgewise Therapeutics And Other Big Stocks Moving Higher On Tuesday
June 27, 2023
U.S. stocks traded higher, with the Dow Joned gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Edgewise Therapeutics Touts Positive Data From Investigational Drug In Form Of Muscular Dystrophy
June 27, 2023
Edgewise Therapeutics Inc (NASDAQ: EWTX) released 12-month topline results from the ARCH study, an open-label, single-center study assessing EDG-5506 in adults with
Via
Benzinga
Edgewise Therapeutics Announces Positive 12-Month Topline Results from the ARCH Open Label Study of EDG-5506 in Adults with Becker Muscular Dystrophy (BMD)
June 26, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at the Goldman Sachs Global Healthcare Conference
June 06, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 11, 2023
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at Upcoming Investor Conferences
May 02, 2023
From
Edgewise Therapeutics
Via
Business Wire
Flexing On Muscular Dystrophy, Analyst Expects Almost 200% Upside For Edgewise Therapeutics
May 01, 2023
Truist initiated coverage on Edgewise Therapeutics Inc (NASDAQ: EWTX) with a Buy rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
May 01, 2023
Via
Benzinga
Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday
April 25, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
April 19, 2023
Tiziana Life Sciences (NASDAQ: TLSA), a London-based biotechnology company, is developing a first-in-class drug, Foralumab. Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) at the...
Via
Benzinga
Edgewise Therapeutics Announces Journal of Clinical Investigation Publication of Key Preclinical Data Linking Modulation of Fast Skeletal Muscle Contraction to Protection of Skeletal Muscle in Models of Duchenne Muscular Dystrophy (DMD)
March 30, 2023
From
Edgewise Therapeutics
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.